Investigator profile
Dr Paul Wabnitz, MD, PhD, FRACP
Medical Director and Lead Principal Investigator, DECENTRA Clinical — St Andrew’s Hospital, Adelaide.
Dr Paul Wabnitz, MD, PhD, FRACP is a specialist physician and experienced trial investigator. He directs medical governance at DECENTRA, a hospital-integrated clinical research centre conducting Phase I, II and III (and selected Phase IV) patient studies for sponsors and CROs in the USA, EU, UK, China, Korea and Australia.
Oversight covers screening, dosing, escalation, overnight observation and extension studies. The site matches eligibility against a statewide, multi-indication patient database before first visit, and operates with on-site pharmacy, laboratory, radiology and 24/7 hospital medical support.
Areas of investigator focus
- Hospital-integrated Phase I, II and III patient studies
- Ocular pharmacology and dry eye disease, with dedicated ocular diagnostics on campus
- Complex patient studies requiring washout, overnight observation or escalation
- First-in-human and early-phase protocols under hospital medical governance
Publications and CV
A full curriculum vitae and selected publications are provided to sponsors after an introductory discussion and a Confidential Disclosure Agreement (CDA). We do not post protocol-level or unpublished data on this page.
- Full investigator CV
- Selected peer-reviewed publications and abstracts
- Indication-specific trial experience (without confidential protocol detail)
- Site inspection and audit history on request
For PubMed and name searches: Dr Paul Wabnitz, MD, PhD, FRACP — DECENTRA Clinical, St Andrew’s Hospital, Adelaide, South Australia.
Request investigator materials
Use the feasibility form or email clinicaltrials@decentraclinical.com with organisation, indication and preferred times for a call. Do not send a protocol until a CDA is in place.
Go to feasibility form